. High-resolution fragmentation spectrum of the m/z 576.6180 ion (z = 3; precursor error 0.2 ppm) from HPLC Peak 1 obtained on a QExactive Plus instrument (Thermo Scientific, Waltham, MA, USA) (A); the peptide sequence was interpreted by the PEAKS 8 de novo sequencing software. The average local confidence was set to 99%, and the local confidence score for each amino acid (i.e., "the likelihood of each amino acid assignment") was ≥98%. (B) Ion table showing the calculated mass of possible fragment ions. All fragment ions matching a peak within the mass error tolerance were colored blue (b-ion series) or red (y ion series). The lower graph shows the mass error distribution of all matched fragment ions (represented by blue and red dots).
(A) (B) Figure S2 . High-resolution fragmentation spectrum of the m/z 614.9611 ion (z = 3; precursor error 1.2 ppm) from HPLC Peak 2 obtained on a QExactive Plus instrument (A). The peptide sequence was interpreted by the PEAKS 8 de novo sequencing software. The average local confidence was set to 99%, and the local confidence score for each amino acid (i.e., "the likelihood of each amino acid assignment") was ≥98%. (B) Ion table showing the calculated mass of possible fragment ions. All fragment ions matching a peak within the mass error tolerance were colored blue (b-ion series) or red (y ion series). The lower graph shows the mass error distribution of all matched fragment ions (represented by blue and red dots).
(A) (B) Figure S3 . High-resolution fragmentation spectrum of the m/z 864.4214 ion (z = 2; precursor error −2.1 ppm) from HPLC Peak 2 obtained on a QExactive Plus instrument (A). The peptide sequence was interpreted by the PEAKS 8 de novo sequencing software. The average local confidence was set to 99%, and the local confidence score for each amino acid (i.e., "the likelihood of each amino acid assignment") was ≥98%. MS data were acquired using a Q Exactive Plus high resolution instrument. The similarity-based alignment was performed by the PepExplorer software, using the following search parameters: minimum identity = 75%; minimum number of residues per peptide = 6; substitution matrix = PAM30MS. Under these conditions, the sequence coverage obtained for BlatPII-c was 22.1%. Figure S8 . Sequence coverage of mature BlatPII-c showing de novo sequenced tryptic peptides from HPLC Peak 2 with average local confidence (ALC) ≥99%, according to PEAKS 8 De Novo software. MS data were acquired using a Q Exactive Plus high resolution instrument. The similarity-based alignment was performed by the PepExplorer software, using the following search parameters: minimum identity = 75%; minimum number of residues per peptide = 6; substitution matrix = PAM30MS. Under these conditions, the sequence coverage obtained for BlatPII-c was 49.1%.
